Competent Cells Industry Research Report 2024
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to 'shock' it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
According to APO Research, The global Competent Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Competent Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Competent Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
- Chemically Competent Cells
- Electrocompetent Cells
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Competent Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Competent Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Competent Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Chemically Competent Cells
2.2.3 Electrocompetent Cells
2.3 Competent Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Subcloning & Routine Cloning
2.3.3 Phage Display Library Construction
2.3.4 Toxic/Unstable DNA Cloning
2.3.5 High-Throughput Cloning
2.3.6 Protein Expression
2.3.7 Mutagenesis
2.3.8 Single-Stranded DNA Production
2.3.9 Bacmid Creation
2.3.10 Cre-Lox Recombination (PIR1/PIR2)
2.4 Assumptions and Limitations
3 COMPETENT CELLS BREAKDOWN DATA BY TYPE
3.1 Global Competent Cells Historic Market Size by Type (2019-2024)
3.2 Global Competent Cells Forecasted Market Size by Type (2025-2030)
4 COMPETENT CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Competent Cells Historic Market Size by Application (2019-2024)
4.2 Global Competent Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Competent Cells Market Perspective (2019-2030)
5.2 Global Competent Cells Growth Trends by Region
5.2.1 Global Competent Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Competent Cells Historic Market Size by Region (2019-2024)
5.2.3 Competent Cells Forecasted Market Size by Region (2025-2030)
5.3 Competent Cells Market Dynamics
5.3.1 Competent Cells Industry Trends
5.3.2 Competent Cells Market Drivers
5.3.3 Competent Cells Market Challenges
5.3.4 Competent Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Competent Cells Players by Revenue
6.1.1 Global Top Competent Cells Players by Revenue (2019-2024)
6.1.2 Global Competent Cells Revenue Market Share by Players (2019-2024)
6.2 Global Competent Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Competent Cells Head office and Area Served
6.4 Global Competent Cells Players, Product Type & Application
6.5 Global Competent Cells Players, Date of Enter into This Industry
6.6 Global Competent Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Competent Cells Market Size (2019-2030)
7.2 North America Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Competent Cells Market Size by Country (2019-2024)
7.4 North America Competent Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Competent Cells Market Size (2019-2030)
8.2 Europe Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Competent Cells Market Size by Country (2019-2024)
8.4 Europe Competent Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Competent Cells Market Size (2019-2030)
9.2 Asia-Pacific Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Competent Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Competent Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Competent Cells Market Size (2019-2030)
10.2 Latin America Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Competent Cells Market Size by Country (2019-2024)
10.4 Latin America Competent Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Competent Cells Market Size (2019-2030)
11.2 Middle East & Africa Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Competent Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Competent Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Merck KGaA
12.1.1 Merck KGaA Company Information
12.1.2 Merck KGaA Business Overview
12.1.3 Merck KGaA Revenue in Competent Cells Business (2019-2024)
12.1.4 Merck KGaA Competent Cells Product Portfolio
12.1.5 Merck KGaA Recent Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Revenue in Competent Cells Business (2019-2024)
12.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
12.2.5 Thermo Fisher Scientific Recent Developments
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Information
12.3.2 Agilent Technologies Business Overview
12.3.3 Agilent Technologies Revenue in Competent Cells Business (2019-2024)
12.3.4 Agilent Technologies Competent Cells Product Portfolio
12.3.5 Agilent Technologies Recent Developments
12.4 Takara Bio
12.4.1 Takara Bio Company Information
12.4.2 Takara Bio Business Overview
12.4.3 Takara Bio Revenue in Competent Cells Business (2019-2024)
12.4.4 Takara Bio Competent Cells Product Portfolio
12.4.5 Takara Bio Recent Developments
12.5 Promega Corporation
12.5.1 Promega Corporation Company Information
12.5.2 Promega Corporation Business Overview
12.5.3 Promega Corporation Revenue in Competent Cells Business (2019-2024)
12.5.4 Promega Corporation Competent Cells Product Portfolio
12.5.5 Promega Corporation Recent Developments
12.6 Beijing TransGen Biotech
12.6.1 Beijing TransGen Biotech Company Information
12.6.2 Beijing TransGen Biotech Business Overview
12.6.3 Beijing TransGen Biotech Revenue in Competent Cells Business (2019-2024)
12.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
12.6.5 Beijing TransGen Biotech Recent Developments
12.7 GeneScript Corporation
12.7.1 GeneScript Corporation Company Information
12.7.2 GeneScript Corporation Business Overview
12.7.3 GeneScript Corporation Revenue in Competent Cells Business (2019-2024)
12.7.4 GeneScript Corporation Competent Cells Product Portfolio
12.7.5 GeneScript Corporation Recent Developments
12.8 Yeastern Biotech
12.8.1 Yeastern Biotech Company Information
12.8.2 Yeastern Biotech Business Overview
12.8.3 Yeastern Biotech Revenue in Competent Cells Business (2019-2024)
12.8.4 Yeastern Biotech Competent Cells Product Portfolio
12.8.5 Yeastern Biotech Recent Developments
12.9 New England Biolabs
12.9.1 New England Biolabs Company Information
12.9.2 New England Biolabs Business Overview
12.9.3 New England Biolabs Revenue in Competent Cells Business (2019-2024)
12.9.4 New England Biolabs Competent Cells Product Portfolio
12.9.5 New England Biolabs Recent Developments
12.10 QIAGEN N.V.
12.10.1 QIAGEN N.V. Company Information
12.10.2 QIAGEN N.V. Business Overview
12.10.3 QIAGEN N.V. Revenue in Competent Cells Business (2019-2024)
12.10.4 QIAGEN N.V. Competent Cells Product Portfolio
12.10.5 QIAGEN N.V. Recent Developments
12.11 OriGene Technologies
12.11.1 OriGene Technologies Company Information
12.11.2 OriGene Technologies Business Overview
12.11.3 OriGene Technologies Revenue in Competent Cells Business (2019-2024)
12.11.4 OriGene Technologies Competent Cells Product Portfolio
12.11.5 OriGene Technologies Recent Developments
12.12 Lucigen
12.12.1 Lucigen Company Information
12.12.2 Lucigen Business Overview
12.12.3 Lucigen Revenue in Competent Cells Business (2019-2024)
12.12.4 Lucigen Competent Cells Product Portfolio
12.12.5 Lucigen Recent Developments
12.13 Zymo Research
12.13.1 Zymo Research Company Information
12.13.2 Zymo Research Business Overview
12.13.3 Zymo Research Revenue in Competent Cells Business (2019-2024)
12.13.4 Zymo Research Competent Cells Product Portfolio
12.13.5 Zymo Research Recent Developments
12.14 Bio-Rad Laboratories
12.14.1 Bio-Rad Laboratories Company Information
12.14.2 Bio-Rad Laboratories Business Overview
12.14.3 Bio-Rad Laboratories Revenue in Competent Cells Business (2019-2024)
12.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
12.14.5 Bio-Rad Laboratories Recent Developments
12.15 Bioline
12.15.1 Bioline Company Information
12.15.2 Bioline Business Overview
12.15.3 Bioline Revenue in Competent Cells Business (2019-2024)
12.15.4 Bioline Competent Cells Product Portfolio
12.15.5 Bioline Recent Developments
12.16 Delphi Genetics
12.16.1 Delphi Genetics Company Information
12.16.2 Delphi Genetics Business Overview
12.16.3 Delphi Genetics Revenue in Competent Cells Business (2019-2024)
12.16.4 Delphi Genetics Competent Cells Product Portfolio
12.16.5 Delphi Genetics Recent Developments
12.17 IBA GmBH
12.17.1 IBA GmBH Company Information
12.17.2 IBA GmBH Business Overview
12.17.3 IBA GmBH Revenue in Competent Cells Business (2019-2024)
12.17.4 IBA GmBH Competent Cells Product Portfolio
12.17.5 IBA GmBH Recent Developments
12.18 Cell Applications
12.18.1 Cell Applications Company Information
12.18.2 Cell Applications Business Overview
12.18.3 Cell Applications Revenue in Competent Cells Business (2019-2024)
12.18.4 Cell Applications Competent Cells Product Portfolio
12.18.5 Cell Applications Recent Developments
12.19 BioDynamics Laboratory
12.19.1 BioDynamics Laboratory Company Information
12.19.2 BioDynamics Laboratory Business Overview
12.19.3 BioDynamics Laboratory Revenue in Competent Cells Business (2019-2024)
12.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
12.19.5 BioDynamics Laboratory Recent Developments
12.20 Scarab Genomics
12.20.1 Scarab Genomics Company Information
12.20.2 Scarab Genomics Business Overview
12.20.3 Scarab Genomics Revenue in Competent Cells Business (2019-2024)
12.20.4 Scarab Genomics Competent Cells Product Portfolio
12.20.5 Scarab Genomics Recent Developments
12.21 GCC Biotech
12.21.1 GCC Biotech Company Information
12.21.2 GCC Biotech Business Overview
12.21.3 GCC Biotech Revenue in Competent Cells Business (2019-2024)
12.21.4 GCC Biotech Competent Cells Product Portfolio
12.21.5 GCC Biotech Recent Developments
12.22 SMOBIO Technology
12.22.1 SMOBIO Technology Company Information
12.22.2 SMOBIO Technology Business Overview
12.22.3 SMOBIO Technology Revenue in Competent Cells Business (2019-2024)
12.22.4 SMOBIO Technology Competent Cells Product Portfolio
12.22.5 SMOBIO Technology Recent Developments
12.23 Edge BioSystems
12.23.1 Edge BioSystems Company Information
12.23.2 Edge BioSystems Business Overview
12.23.3 Edge BioSystems Revenue in Competent Cells Business (2019-2024)
12.23.4 Edge BioSystems Competent Cells Product Portfolio
12.23.5 Edge BioSystems Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Competent Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Chemically Competent Cells
2.2.3 Electrocompetent Cells
2.3 Competent Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Subcloning & Routine Cloning
2.3.3 Phage Display Library Construction
2.3.4 Toxic/Unstable DNA Cloning
2.3.5 High-Throughput Cloning
2.3.6 Protein Expression
2.3.7 Mutagenesis
2.3.8 Single-Stranded DNA Production
2.3.9 Bacmid Creation
2.3.10 Cre-Lox Recombination (PIR1/PIR2)
2.4 Assumptions and Limitations
3 COMPETENT CELLS BREAKDOWN DATA BY TYPE
3.1 Global Competent Cells Historic Market Size by Type (2019-2024)
3.2 Global Competent Cells Forecasted Market Size by Type (2025-2030)
4 COMPETENT CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Competent Cells Historic Market Size by Application (2019-2024)
4.2 Global Competent Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Competent Cells Market Perspective (2019-2030)
5.2 Global Competent Cells Growth Trends by Region
5.2.1 Global Competent Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Competent Cells Historic Market Size by Region (2019-2024)
5.2.3 Competent Cells Forecasted Market Size by Region (2025-2030)
5.3 Competent Cells Market Dynamics
5.3.1 Competent Cells Industry Trends
5.3.2 Competent Cells Market Drivers
5.3.3 Competent Cells Market Challenges
5.3.4 Competent Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Competent Cells Players by Revenue
6.1.1 Global Top Competent Cells Players by Revenue (2019-2024)
6.1.2 Global Competent Cells Revenue Market Share by Players (2019-2024)
6.2 Global Competent Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Competent Cells Head office and Area Served
6.4 Global Competent Cells Players, Product Type & Application
6.5 Global Competent Cells Players, Date of Enter into This Industry
6.6 Global Competent Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Competent Cells Market Size (2019-2030)
7.2 North America Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Competent Cells Market Size by Country (2019-2024)
7.4 North America Competent Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Competent Cells Market Size (2019-2030)
8.2 Europe Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Competent Cells Market Size by Country (2019-2024)
8.4 Europe Competent Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Competent Cells Market Size (2019-2030)
9.2 Asia-Pacific Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Competent Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Competent Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Competent Cells Market Size (2019-2030)
10.2 Latin America Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Competent Cells Market Size by Country (2019-2024)
10.4 Latin America Competent Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Competent Cells Market Size (2019-2030)
11.2 Middle East & Africa Competent Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Competent Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Competent Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Merck KGaA
12.1.1 Merck KGaA Company Information
12.1.2 Merck KGaA Business Overview
12.1.3 Merck KGaA Revenue in Competent Cells Business (2019-2024)
12.1.4 Merck KGaA Competent Cells Product Portfolio
12.1.5 Merck KGaA Recent Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Revenue in Competent Cells Business (2019-2024)
12.2.4 Thermo Fisher Scientific Competent Cells Product Portfolio
12.2.5 Thermo Fisher Scientific Recent Developments
12.3 Agilent Technologies
12.3.1 Agilent Technologies Company Information
12.3.2 Agilent Technologies Business Overview
12.3.3 Agilent Technologies Revenue in Competent Cells Business (2019-2024)
12.3.4 Agilent Technologies Competent Cells Product Portfolio
12.3.5 Agilent Technologies Recent Developments
12.4 Takara Bio
12.4.1 Takara Bio Company Information
12.4.2 Takara Bio Business Overview
12.4.3 Takara Bio Revenue in Competent Cells Business (2019-2024)
12.4.4 Takara Bio Competent Cells Product Portfolio
12.4.5 Takara Bio Recent Developments
12.5 Promega Corporation
12.5.1 Promega Corporation Company Information
12.5.2 Promega Corporation Business Overview
12.5.3 Promega Corporation Revenue in Competent Cells Business (2019-2024)
12.5.4 Promega Corporation Competent Cells Product Portfolio
12.5.5 Promega Corporation Recent Developments
12.6 Beijing TransGen Biotech
12.6.1 Beijing TransGen Biotech Company Information
12.6.2 Beijing TransGen Biotech Business Overview
12.6.3 Beijing TransGen Biotech Revenue in Competent Cells Business (2019-2024)
12.6.4 Beijing TransGen Biotech Competent Cells Product Portfolio
12.6.5 Beijing TransGen Biotech Recent Developments
12.7 GeneScript Corporation
12.7.1 GeneScript Corporation Company Information
12.7.2 GeneScript Corporation Business Overview
12.7.3 GeneScript Corporation Revenue in Competent Cells Business (2019-2024)
12.7.4 GeneScript Corporation Competent Cells Product Portfolio
12.7.5 GeneScript Corporation Recent Developments
12.8 Yeastern Biotech
12.8.1 Yeastern Biotech Company Information
12.8.2 Yeastern Biotech Business Overview
12.8.3 Yeastern Biotech Revenue in Competent Cells Business (2019-2024)
12.8.4 Yeastern Biotech Competent Cells Product Portfolio
12.8.5 Yeastern Biotech Recent Developments
12.9 New England Biolabs
12.9.1 New England Biolabs Company Information
12.9.2 New England Biolabs Business Overview
12.9.3 New England Biolabs Revenue in Competent Cells Business (2019-2024)
12.9.4 New England Biolabs Competent Cells Product Portfolio
12.9.5 New England Biolabs Recent Developments
12.10 QIAGEN N.V.
12.10.1 QIAGEN N.V. Company Information
12.10.2 QIAGEN N.V. Business Overview
12.10.3 QIAGEN N.V. Revenue in Competent Cells Business (2019-2024)
12.10.4 QIAGEN N.V. Competent Cells Product Portfolio
12.10.5 QIAGEN N.V. Recent Developments
12.11 OriGene Technologies
12.11.1 OriGene Technologies Company Information
12.11.2 OriGene Technologies Business Overview
12.11.3 OriGene Technologies Revenue in Competent Cells Business (2019-2024)
12.11.4 OriGene Technologies Competent Cells Product Portfolio
12.11.5 OriGene Technologies Recent Developments
12.12 Lucigen
12.12.1 Lucigen Company Information
12.12.2 Lucigen Business Overview
12.12.3 Lucigen Revenue in Competent Cells Business (2019-2024)
12.12.4 Lucigen Competent Cells Product Portfolio
12.12.5 Lucigen Recent Developments
12.13 Zymo Research
12.13.1 Zymo Research Company Information
12.13.2 Zymo Research Business Overview
12.13.3 Zymo Research Revenue in Competent Cells Business (2019-2024)
12.13.4 Zymo Research Competent Cells Product Portfolio
12.13.5 Zymo Research Recent Developments
12.14 Bio-Rad Laboratories
12.14.1 Bio-Rad Laboratories Company Information
12.14.2 Bio-Rad Laboratories Business Overview
12.14.3 Bio-Rad Laboratories Revenue in Competent Cells Business (2019-2024)
12.14.4 Bio-Rad Laboratories Competent Cells Product Portfolio
12.14.5 Bio-Rad Laboratories Recent Developments
12.15 Bioline
12.15.1 Bioline Company Information
12.15.2 Bioline Business Overview
12.15.3 Bioline Revenue in Competent Cells Business (2019-2024)
12.15.4 Bioline Competent Cells Product Portfolio
12.15.5 Bioline Recent Developments
12.16 Delphi Genetics
12.16.1 Delphi Genetics Company Information
12.16.2 Delphi Genetics Business Overview
12.16.3 Delphi Genetics Revenue in Competent Cells Business (2019-2024)
12.16.4 Delphi Genetics Competent Cells Product Portfolio
12.16.5 Delphi Genetics Recent Developments
12.17 IBA GmBH
12.17.1 IBA GmBH Company Information
12.17.2 IBA GmBH Business Overview
12.17.3 IBA GmBH Revenue in Competent Cells Business (2019-2024)
12.17.4 IBA GmBH Competent Cells Product Portfolio
12.17.5 IBA GmBH Recent Developments
12.18 Cell Applications
12.18.1 Cell Applications Company Information
12.18.2 Cell Applications Business Overview
12.18.3 Cell Applications Revenue in Competent Cells Business (2019-2024)
12.18.4 Cell Applications Competent Cells Product Portfolio
12.18.5 Cell Applications Recent Developments
12.19 BioDynamics Laboratory
12.19.1 BioDynamics Laboratory Company Information
12.19.2 BioDynamics Laboratory Business Overview
12.19.3 BioDynamics Laboratory Revenue in Competent Cells Business (2019-2024)
12.19.4 BioDynamics Laboratory Competent Cells Product Portfolio
12.19.5 BioDynamics Laboratory Recent Developments
12.20 Scarab Genomics
12.20.1 Scarab Genomics Company Information
12.20.2 Scarab Genomics Business Overview
12.20.3 Scarab Genomics Revenue in Competent Cells Business (2019-2024)
12.20.4 Scarab Genomics Competent Cells Product Portfolio
12.20.5 Scarab Genomics Recent Developments
12.21 GCC Biotech
12.21.1 GCC Biotech Company Information
12.21.2 GCC Biotech Business Overview
12.21.3 GCC Biotech Revenue in Competent Cells Business (2019-2024)
12.21.4 GCC Biotech Competent Cells Product Portfolio
12.21.5 GCC Biotech Recent Developments
12.22 SMOBIO Technology
12.22.1 SMOBIO Technology Company Information
12.22.2 SMOBIO Technology Business Overview
12.22.3 SMOBIO Technology Revenue in Competent Cells Business (2019-2024)
12.22.4 SMOBIO Technology Competent Cells Product Portfolio
12.22.5 SMOBIO Technology Recent Developments
12.23 Edge BioSystems
12.23.1 Edge BioSystems Company Information
12.23.2 Edge BioSystems Business Overview
12.23.3 Edge BioSystems Revenue in Competent Cells Business (2019-2024)
12.23.4 Edge BioSystems Competent Cells Product Portfolio
12.23.5 Edge BioSystems Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
